Reappointment of Ms. Sundari R. Pisupati
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited held its Board meeting on May 23, 2026, approving several routine corporate matters. The Board recommended a final dividend of Rs 3.5 per share (35% on face value) for FY 2026, subject to shareholder approval at the 28th AGM on July 29, 2026. The meeting also approved the reappointment of Ms. Sundari R. Pisupati as an Independent Director for a second term of 5 years from September 16, 2026 to September 15, 2031. Additionally, the Board reappointed two other key directors (Dr. Ramesh Kancharla as Chairman-MD and Dr. Dinesh Kumar Chirla as Whole Time Director) and Mr. Santanu Mukherjee as another Independent Director, all for 5-year terms. The audited financial results for Q4 and FY ended March 31, 2026 received an unmodified opinion from S.R. Batliboi & Associates LLP.
The reappointments indicate continuity in leadership and board composition. The dividend recommendation provides positive shareholder returns. No material governance concerns arise from this filing.